Wellquest

Wellquest, the clinical research division of Nicholas Piramal, becomes the first Indian CRO to receive the Statement of GCP (Good Clinical Practices) Compliance from the UK-MHRA (Medicines & Healthcare Products Regulatory Agency), for clinical studies carried out to support the registration of generic products in the international regulated markets.

Its services include evaluation of generic and NDDS products and Phase I-III clinical trials with NCEs (New Chemical Entities), herbal and biotech products.

Wellquest has facilities at Hyderabad and Mumbai